VEDS Clinical Trials
We Deserve More Tomorrows
VEDS Clinical Trials
Clinical Trial
Zevra Therapeutics are conducting a clinical trial in the U.S. to evaluate the efficacy of a medicine known as celiprolol for the treatment of Vascular Ehlers-Danlos Syndrome (VEDS).
Sponsored by
Zevra Therapeutics.
600
We support over 600 members affected by Vascular EDS.
COL3A1
Vascular EDS is caused by a mutation in the COL3A1 gene.
740
It is estimated around 740 people have Vascular EDS in the UK.
